Solution phase synthesis of potential DNA-binding molecules based on the PNA backbone

Tetrahedron Letters

Volumn 40, Issue 3, 1999, Pages 419-422

  Challa, Hemavathi ^a   Woski, Stephen A ^a  

^a UNIVERSITY OF ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; DNA; GLYCINE DERIVATIVE; N (2 AMINOETHYL)GLYCINE; OLIGOMER; PEPTIDE NUCLEIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CHROMATOGRAPHY; DNA BINDING; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS;

EID: 0033555233     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(98)02385-5     Document Type: Article

References (26)

1. For reviews, see: (a) Waring, M. J. Ann. Rev. Biochem. 1981, 50, 159;
2. (b) Molecular Aspects of Anti-Cancer Drug Action. Neidle, S. and Waring, M. J., Eds. Verlag Chemie: Weinheim, 1983;
3. (c) Neidle, S.; Abraham, Z. CRC Crit. Rev. in Biochem. 1984, 17, 73.
4. Waring, M. J.; Wakelin, L. P. G. Nature 1974, 252, 653.
5. For a review, see: Wakelin, L. P. G. Med. Res. Rev. 1986,6, 275.
6. (a) Gaugain, B.; Markovits, J.; Le Pecq, J.-B.; Roques, B. P. FEBS Lett. 1984, 169, 123;
7. (b) Laugaa, P.; Markovits J.; Delbarre, A.; Le Pecq, J.-B.; Roques, B. P. Biochemistry 1985, 24, 5567;
8. (c) Atwell, G. J.; Baguley, B. C.; Wilmanska, D.; Denny, W. A. J. Med. Chem. 1986,29, 69;
9. (d) Nielsen, P. E.; Zhen, W.; Henriksen, U.; Buchardt, O. Biochemistry 1988, 27, 67.
10. Neilsen, P. E.; Egholm, M.; Berg, R. H.; Buchardt, O. Science 1991, 254, 1497.
11. For some recent reviews, see: (a) Hyrup, B.; Nielsen, P. E. Bioorg. Med. Chem. 1996, 4, 5;
12. (b) Dueholm, K. L.; Nielsen, P. E. New. J. Chem. 1997, 21, 19;
13. (c) Nielsen, P. E.; Haaima, G. Chem. Soc. Rev. 1997, 73.
14. (a) Armitage, B.; Ly, D.; Koch, T.; Frydenlund, H.; Orum, H.; Batz, H. G.; Schuster, G. B. Proc. Natl. Acad. Sci. USA 1997, 94, 12320;
15. (b) Armitage, B.; Koch, T.; Frydenlund, H.; Orum, H.; Schuster, G. B. Nucleic Acids Res. 1998, 26, 715.
16. Crother, D. M. Biopolymers 1968, 6, 575.
17. Hyrup, B.; Egholm, M.; Buchardt, O.; Nielsen, P. E. Bioorg. Med. Chem. Lett. 1996, 6, 1083.
18. Chen, F.-M. Nucleic Acids Res. 1983, 11, 7231.
19. The use of this residue (without any synthetic details) has been reported in Ref. 7.
20. Thomson, S. A.; Josey, J. A.; Cadilla, R.; Gaul, M. D.; Hassman, C. F.; Luzzio, M. J.; Pipe, A. J.; Reed, K. L.; Ricca, D. J.; Wiethe, R. W.; Noble, S. A. Tetrahedron 1995, 51, 6179.
21. 3) δ 7.75 (d, 2H), 7.59 (d, 2H), 7.40 (t, 2H), 7.31 (t, 2H), 4.39 & 4.34 (rotomer d, 2H), 4.21 (t, 1H), 3.94 & 3.90 (rotomer s, 2H), 3.54 & 3.48 (rotomer t, 2H), 3.36 (m, 2H), 1.51 & 1.49 (rotomer s, 9H).
22. Farese, A.; Patino, N.; Condom, R.; Dalleu, S.; Guedj, R. Tetrahedron Lett. 1996, 37, 1413.
23. Woski, S. A.; Challa, H. Unpublished results.
24. Lloyd-Williams, P.; Albericio, F.; Giralt, E. Chemical Approaches to the Synthesis of Peptides and Proteins. CRC: Boca Raton, FL, 1997, and references cited therein.
25. 4 and concentrated in vacuo. The resulting residue was purified by silica gel chromatography.
26. +.